Research ArticleArticle
Clinical Spectrum, Treatment, and Outcome of Patients with Type II Mixed Cryoglobulinemia without Evidence of Hepatitis C Infection
Laure Foessel, Jean-François Besancenot, Gilles Blaison, Nadine Magy-Bertrand, Roland Jaussaud, Yves Etienne, François Maurier, Sylvain Audia and Thierry Martin
The Journal of Rheumatology January 2011, jrheum.100898; DOI: https://doi.org/10.3899/jrheum.100898
Laure Foessel
Jean-François Besancenot
Gilles Blaison
Nadine Magy-Bertrand
Roland Jaussaud
Yves Etienne
François Maurier
Sylvain Audia
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Clinical Spectrum, Treatment, and Outcome of Patients with Type II Mixed Cryoglobulinemia without Evidence of Hepatitis C Infection
Laure Foessel, Jean-François Besancenot, Gilles Blaison, Nadine Magy-Bertrand, Roland Jaussaud, Yves Etienne, François Maurier, Sylvain Audia, Thierry Martin
The Journal of Rheumatology Jan 2011, jrheum.100898; DOI: 10.3899/jrheum.100898
Clinical Spectrum, Treatment, and Outcome of Patients with Type II Mixed Cryoglobulinemia without Evidence of Hepatitis C Infection
Laure Foessel, Jean-François Besancenot, Gilles Blaison, Nadine Magy-Bertrand, Roland Jaussaud, Yves Etienne, François Maurier, Sylvain Audia, Thierry Martin
The Journal of Rheumatology Jan 2011, jrheum.100898; DOI: 10.3899/jrheum.100898